Clinical Trial Update: A Randomized Controlled Trial Evaluating the Effectiveness of a Novel Risk-Stratified Screening Strategy for Lung Cancer [NA]

View source ↗

Summary

A randomized controlled trial evaluating a novel risk-stratified screening strategy for lung cancer is planned and currently not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lung Cancer

Snippet

Sponsor: The First Affiliated Hospital of Guangzhou Medical University | Conditions: Lung Cancer Screening | NA | Status: NOT_YET_RECRUITING